home / stock / imux / imux short
Short Information | Immunic Inc. (NYSE:IMUX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 13,384 |
Total Actual Volume | 423,058 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 669 |
Average Short Percentage | 4.16% |
Is there a IMUX Short Squeeze or Breakout about to happen?
See the IMUX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $8.72 | $8.91 | $8.9799 | $8.5022 | 4,415 | 109 | 2.47% |
02-11-2020 | $8.9028 | $8.72 | $8.95 | $8.44 | 6,229 | 249 | 4% |
02-10-2020 | $8.5146 | $8.92 | $8.92 | $8.5146 | 9,197 | 1,508 | 16.4% |
02-07-2020 | $8.80 | $8.85 | $9.05 | $8.65 | 24,540 | 149 | 0.61% |
02-06-2020 | $9.18 | $8.87 | $9.18 | $8.70 | 18,481 | 77 | 0.42% |
02-05-2020 | $9.29 | $8.94 | $9.50 | $8.8663 | 5,224 | 859 | 16.44% |
02-04-2020 | $9.37 | $9.17 | $9.37 | $8.227 | 57,075 | 2,571 | 4.5% |
02-03-2020 | $8.96 | $8.96 | $8.96 | $8.189 | 21,970 | 709 | 3.23% |
01-31-2020 | $8.30 | $8.33 | $8.5195 | $8.08 | 24,716 | 199 | 0.81% |
01-30-2020 | $8.21 | $8.35 | $8.53 | $8.1249 | 19,657 | 9 | 0.05% |
01-29-2020 | $8.73 | $8.12 | $8.98 | $8.12 | 7,110 | 280 | 3.94% |
01-28-2020 | $8.12 | $8.67 | $8.76 | $8.12 | 6,806 | 411 | 6.04% |
01-27-2020 | $8.28 | $8.03 | $8.73 | $8.03 | 7,883 | 66 | 0.84% |
01-24-2020 | $8.79 | $8.215 | $8.932 | $8.15 | 25,046 | 1,258 | 5.02% |
01-23-2020 | $9.15 | $8.61 | $9.20 | $8.61 | 13,648 | 108 | 0.79% |
01-22-2020 | $9.22 | $9.04 | $9.46 | $8.61 | 50,733 | 351 | 0.69% |
01-21-2020 | $9.56 | $9.34 | $9.7399 | $9.13 | 26,063 | 3,143 | 12.06% |
01-17-2020 | $9.81 | $9.53 | $9.90 | $9.41 | 56,221 | 601 | 1.07% |
01-16-2020 | $9.49 | $9.80 | $9.80 | $9.49 | 20,514 | 282 | 1.37% |
01-15-2020 | $9.32 | $9.38 | $9.499 | $9.01 | 17,530 | 445 | 2.54% |
News, Short Squeeze, Breakout and More Instantly...
Immunic Appoints Jason Tardio as Chief Operating Officer and President PR Newswire – Former Novartis and Biogen Executive Brings Extensive Multiple Sclerosis Drug Commercialization Experience to Immunic – – Werner Gladdines, Current Vice President,...
--News Direct-- Immunic Inc CEO Daniel Vitt joined Steve Darling from Proactive to discuss the ongoing challenges and recent developments in treating multiple sclerosis (MS). This interview took place in conjunction with World MS Day, a day dedicated to raising global awareness about this...
Immunic to Participate in Industry and Scientific Conferences in June PR Newswire NEW YORK , May 28, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule thera...